Vincerx Pharma, Inc. financial data

Symbol
VINC on Nasdaq
Industry
Pharmaceutical Preparations
Location
260 Sheridan Avenue, Suite 400, Palo Alto, California
Fiscal year end
December 31
Former names
Vincera Pharma, Inc. (to 1/5/2021), LifeSci Acquisition Corp. (to 12/22/2020)
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 225 % -63.7%
Debt-to-equity 80 % +241%
Return On Equity -301 % -165%
Return On Assets -167 % -82%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.4M shares +0.79%
Common Stock, Shares, Outstanding 21.4M shares +0.79%
Entity Public Float 23M USD +16.2%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 21.4K shares +1%
Weighted Average Number of Shares Outstanding, Diluted 21.4K shares +1%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 12.1M USD -32%
Operating Income (Loss) -34.7M USD +46.6%
Nonoperating Income (Expense) -3.26M USD -187%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -40.2M USD +36.2%
Net Income (Loss) Attributable to Parent -37.9M USD +38%
Earnings Per Share, Basic -1.78 USD/shares +38.6%
Earnings Per Share, Diluted -1.78 USD/shares +38.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.11M USD +13.8%
Marketable Securities, Current 0 USD -100%
Cash, Cash Equivalents, and Short-term Investments 20.8M USD
Other Assets, Current 760K USD -77.4%
Assets, Current 7.68M USD -82.6%
Property, Plant and Equipment, Net 111K USD -32.3%
Operating Lease, Right-of-Use Asset 1.95M USD -33.3%
Other Assets, Noncurrent 138K USD -61%
Assets 11.1M USD -76.6%
Accounts Payable, Current 2.31M USD -62.5%
Accrued Liabilities, Current 1.73M USD -48.5%
Liabilities, Current 10.6M USD -0.73%
Operating Lease, Liability, Noncurrent 1.02M USD -54%
Other Liabilities, Noncurrent 50K USD 0%
Liabilities 11.7M USD -9.84%
Accumulated Other Comprehensive Income (Loss), Net of Tax 60K USD +71.4%
Retained Earnings (Accumulated Deficit) -172M USD -26.4%
Stockholders' Equity Attributable to Parent -622K USD -102%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.5B USD
Liabilities and Equity 11.1M USD -76.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.74M USD +40.9%
Net Cash Provided by (Used in) Financing Activities 5K USD +66.7%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 21.4M shares +0.79%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.66M USD -6.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.19M USD +13.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 37.7M USD +33.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 38.3M USD +32%
Operating Lease, Liability 2.22M USD -32.3%
Depreciation 52M USD -3.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -37.9M USD +38%
Lessee, Operating Lease, Liability, to be Paid 3.04M USD
Property, Plant and Equipment, Gross 256K USD 0%
Operating Lease, Liability, Current 1.2M USD +13.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.37M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.32M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 167K USD -57.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28K USD
Deferred Tax Assets, Operating Loss Carryforwards 15.5M USD +60.5%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 30M shares 0%
Unrecognized Tax Benefits 1.24M USD +26.5%
Operating Lease, Payments 1.28M USD +12%
Additional Paid in Capital 171M USD +0.44%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 13K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 2.71M USD -56.2%
Interest Expense 8K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%